Brief: Prostatype Genomics Submits Medicare Reimbursement Application In U.S. Market For Gene Test Prostatype
30/09/2024 07:24
Sept 30 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* SUBMITS MEDICARE REIMBURSEMENT APPLICATION IN THE US
MARKET FOR
ITS GENE TEST PROSTATYPE
Source text for Eikon: ID:nMFNgMbYl
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants